Kyowa Hakko Kirin Co., Ltd. - Strategy, SWOT and Corporate Finance Report
Summary
Kyowa Hakko Kirin Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
Kyowa Hakko Kirin Co. Ltd (Kyowa Hakko or 'the company'), a subsidiary of Kirin Holdings Company Limited, is a Japan-based provider of pharmaceuticals and bio-chemicals. It is primarily involved in the development and distribution of biotechnological products with major focus on oncology, nephrology and central nervous systems. The company offers its products under the brands: Pasetocin, Fortimicin, Sagamicin, Leunase, Adriacin, Hysron, Farmorubicin, Platosin, Navelbine, Depakene, Meditrans, Inovan, Coniel, Pre Dopa, Dobupum, Imagenil, Nauzelin, Glumin, Glumal, Navoban, Allelock, Celtect and Activacin. These products are used to treat hypertension, allergic reactions, anemia and behavioral disorders, to mention a few. It is headquartered in Tokyo, Japan.
Scope
Reasons to Buy
Summary
Kyowa Hakko Kirin Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
Kyowa Hakko Kirin Co. Ltd (Kyowa Hakko or 'the company'), a subsidiary of Kirin Holdings Company Limited, is a Japan-based provider of pharmaceuticals and bio-chemicals. It is primarily involved in the development and distribution of biotechnological products with major focus on oncology, nephrology and central nervous systems. The company offers its products under the brands: Pasetocin, Fortimicin, Sagamicin, Leunase, Adriacin, Hysron, Farmorubicin, Platosin, Navelbine, Depakene, Meditrans, Inovan, Coniel, Pre Dopa, Dobupum, Imagenil, Nauzelin, Glumin, Glumal, Navoban, Allelock, Celtect and Activacin. These products are used to treat hypertension, allergic reactions, anemia and behavioral disorders, to mention a few. It is headquartered in Tokyo, Japan.
Scope
- Detailed information on Kyowa Hakko Kirin Co., Ltd. required for business and competitor intelligence needs.
- A study of the major internal and external factors affecting Kyowa Hakko Kirin Co., Ltd. in the form of a SWOT analysis.
- An in-depth view of the business model of Kyowa Hakko Kirin Co., Ltd. including a breakdown and examination of key business segments.
- Intelligence on Kyowa Hakko Kirin Co., Ltd.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors.
- News about Kyowa Hakko Kirin Co., Ltd., such as business expansion, restructuring, and contract wins.
- Large number of easy-to-grasp charts and graphs that present important data and key trends.
Reasons to Buy
- Gain an understanding of Kyowa Hakko Kirin Co., Ltd. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Kyowa Hakko Kirin Co., Ltd. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers' businesses better.
- Stay up to date on Kyowa Hakko Kirin Co., Ltd.'s business structure, strategy and prospects.
Table of Contents
- Company Snapshot
- Kyowa Hakko Kirin Co., Ltd.: Company Overview
- Kyowa Hakko Kirin Co., Ltd.: Overview and Key Facts
- Kyowa Hakko Kirin Co., Ltd.: Overview
- Kyowa Hakko Kirin Co., Ltd.: Key Facts
- Kyowa Hakko Kirin Co., Ltd.: Key Employees
- Kyowa Hakko Kirin Co., Ltd.: Key Employee Biographies
- Kyowa Hakko Kirin Co., Ltd.: Major Products and Services
- Kyowa Hakko Kirin Co., Ltd.: Company History
- Kyowa Hakko Kirin Co., Ltd.: Management Statement
- Kyowa Hakko Kirin Co., Ltd.: Locations and Subsidiaries
- Kyowa Hakko Kirin Co., Ltd.: Key Competitors
- Kyowa Hakko Kirin Co., Ltd.: Company Analysis
- Kyowa Hakko Kirin Co., Ltd.: Business Description
- Kyowa Hakko Kirin Co., Ltd.: SWOT Analysis
- Kyowa Hakko Kirin Co., Ltd.: SWOT Overview
- Kyowa Hakko Kirin Co., Ltd.: Strengths
- Kyowa Hakko Kirin Co., Ltd.: Weaknesses
- Kyowa Hakko Kirin Co., Ltd.: Opportunities
- Kyowa Hakko Kirin Co., Ltd.: Threats
- Kyowa Hakko Kirin Co., Ltd.: Corporate Financial Deals Activity
- Kyowa Hakko Kirin Co., Ltd.: Financial Deals Overview
- Kyowa Hakko Kirin Co., Ltd.: Targets and Partners
- Kyowa Hakko Kirin Co., Ltd.: Top Deals 2016-2020YTD*
- Kyowa Hakko Kirin Co., Ltd.: Advisors
- Kyowa Hakko Kirin Co., Ltd.: Top Legal Advisors
- Kyowa Hakko Kirin Co., Ltd.: Top Financial Advisors
- Kyowa Hakko Kirin Co., Ltd.: Corporate Venturing
- Kyowa Hakko Kirin Co., Ltd.: Partnership
- Kyowa Hakko Kirin Co., Ltd.: Divestments
- Kyowa Hakko Kirin Co., Ltd.: Recent Developments
- Kyowa Hakko Kirin Co., Ltd.: News and Events Summary
- Kyowa Hakko Kirin Co., Ltd.: Business Expansion
- Kyowa Hakko Kirin Co., Ltd.: Corporate Governance
- Kyowa Hakko Kirin Co., Ltd.: Financial Performance
- Kyowa Hakko Kirin Co., Ltd.: Grants
- Kyowa Hakko Kirin Co., Ltd.: Regulatory and Legal Events
- Kyowa Hakko Kirin Co., Ltd.: Research & Development
- Kyowa Hakko Kirin Co., Ltd.: Strategy and Operations
- Appendix
- Contact Us
- Methodology
- About the Author
List of Tables
Table 1: Kyowa Hakko Kirin Co., Ltd.: Key Facts
Table 2: Kyowa Hakko Kirin Co., Ltd.: Key Employees
Table 3: Kyowa Hakko Kirin Co., Ltd.: Company History
Table 4: Kyowa Hakko Kirin Co., Ltd.: Locations and Subsidiaries
Table 5: Kyowa Hakko Kirin Co., Ltd.: Key Competitors
Table 6: Kyowa Hakko Kirin Co., Ltd.: Deal Activity by Deal Type-Volume (TTM*)
Table 7: Kyowa Hakko Kirin Co., Ltd.: Deal Activity by Deal Type-Volume (2016-YTD*2020)
Table 8: Kyowa Hakko Kirin Co., Ltd.: Targets and Partners
Table 9: Kyowa Hakko Kirin Co., Ltd.: Top Deals 2016-2020YTD*
Table 10: Kyowa Hakko Kirin Co., Ltd.: Legal Advisor Ranking by Value (US$m)
Table 11: Kyowa Hakko Kirin Co., Ltd.: Financial Advisor Ranking by Value (US$m)
Table 12: Kyowa Hakko Kirin Co., Ltd.: Corporate Venturing Volume and Value Trend (2016-YTD*2020)
Table 13: Kyowa Hakko Kirin Co., Ltd.: Corporate Venturing by Geography (2016-YTD*2020)
Table 14: Kyowa Hakko Kirin Co., Ltd.: Partnership Volume and Value Trend (2016-YTD*2020)
Table 15: Kyowa Hakko Kirin Co., Ltd.: Partnership Trend by Deal Type (2016-YTD*2020)
Table 16: Kyowa Hakko Kirin Co., Ltd.: Divestments Volume and Value Trend (2016-YTD*2020)
Table 17: Kyowa Hakko Kirin Co., Ltd.: Divestments by Geography (2016-YTD*2020)
Table 18: Kyowa Hakko Kirin Co., Ltd.: News and Events Summary
Table 19: Kyowa Hakko Kirin Co., Ltd.: Business Expansion
Table 20: Kyowa Hakko Kirin Co., Ltd.: Corporate Governance
Table 21: Kyowa Hakko Kirin Co., Ltd.: Financial Performance
Table 22: Kyowa Hakko Kirin Co., Ltd.: Grants
Table 23: Kyowa Hakko Kirin Co., Ltd.: Regulatory and Legal Events
Table 24: Kyowa Hakko Kirin Co., Ltd.: Research & Development
Table 25: Kyowa Hakko Kirin Co., Ltd.: Strategy and Operations
List of Figures
Figure 1: Kyowa Hakko Kirin Co., Ltd.: Deal Activity by Deal Type-Volume (TTM*)
Figure 2: Kyowa Hakko Kirin Co., Ltd.: Deal Activity by Deal Type-Volume (2016-YTD*2020)
Figure 3: Kyowa Hakko Kirin Co., Ltd.: Corporate Venturing Volume and Value Trend (2016-YTD*2020)
Figure 4: Kyowa Hakko Kirin Co., Ltd.: Corporate Venturing by Geography (2016-YTD*2020)
Figure 5: Kyowa Hakko Kirin Co., Ltd.: Partnership Volume and Value Trend (2016-YTD*2020)
Figure 6: Kyowa Hakko Kirin Co., Ltd.: Partnership Trend by Deal Type (2016-YTD*2020)
Figure 7: Kyowa Hakko Kirin Co., Ltd.: Divestments Volume and Value Trend (2016-YTD*2020)
Figure 8: Kyowa Hakko Kirin Co., Ltd.: Divestments by Geography (2016-YTD*2020)
